Centene (CNC) Stock Forecast & Price Target

$70.83

-1.83 (-2.52%)

(As of 09/6/2024 ET)

Centene - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold
Based on 13 Analyst Ratings

Based on 13 Wall Street analysts who have issued ratings for Centene in the last 12 months, the stock has a consensus rating of "Hold." Out of the 13 analysts, 7 have given a hold rating, and 6 have given a buy rating for CNC.

Consensus Price Target

$85.75
21.06% Upside

High Forecast	$97.00
Average Forecast	$85.75
Low Forecast	$69.00

According to the 13 analysts' twelve-month price targets for Centene, the average price target is $85.75. The highest price target for CNC is $97.00, while the lowest price target for CNC is $69.00. The average price target represents a forecasted upside of 21.06% from the current price of $70.83.

Type	Current Forecast 9/8/23 to 9/7/24	1 Month Ago 8/9/23 to 8/8/24	3 Months Ago 6/10/23 to 6/9/24	1 Year Ago 9/8/22 to 9/8/23
Consensus Rating	Hold	Hold	Hold	Hold
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)	6 Buy rating(s)
Hold	7 Hold rating(s)	9 Hold rating(s)	8 Hold rating(s)	9 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$85.75	$84.36	$84.93	$84.22
Forecasted Upside	21.06% Upside	19.75% Upside	20.90% Upside	22.03% Upside

Get Centene Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for CNC and its competitors with MarketBeat's FREE daily newsletter.

Ad Paradigm Press

Kamala’s Dirty Election Move… Revealed

According to former advisor to the CIA, the Pentagon and the White House Jim Rickards… Kamala and her puppet masters are planning this dirty election move…

Click here now and learn how to prepare.

CNC Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CNC Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Centene Stock vs. The Competition

Type	Centene	Medical Companies	S&P 500
Consensus Rating Score	2.46	2.77	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	21.06% Upside	1,207.55% Upside	11.36% Upside
News Sentiment Rating	Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/5/2024	Barclays 3 of 5 stars		Lower Target	Overweight ➝ Overweight	$98.00 ➝ $97.00	+36.10%
8/19/2024	Cantor Fitzgerald 3 of 5 stars		Reiterated Rating	Overweight ➝ Overweight	$90.00 ➝ $90.00	+14.64%
8/5/2024	Stephens 4 of 5 stars		Reiterated Rating	Equal Weight ➝ Equal Weight	$78.00 ➝ $78.00	+0.41%
8/5/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$81.00 ➝ $93.00	+21.41%
8/2/2024	Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Hold ➝ Hold	$82.00 ➝ $87.00	+11.80%
7/31/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$80.00 ➝ $89.00	+14.68%
Get the Latest News and Ratings for CNC and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Centene and its competitors with MarketBeat's FREE daily newsletter.
7/29/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform ➝ Outperform	$110.00 ➝ $95.00	+32.37%
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$83.00 ➝ $69.00	+6.37%
7/15/2024	Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Buy ➝ Buy	$92.00 ➝ $89.00	+31.50%
7/10/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$85.00 ➝ $80.00	+21.56%
5/30/2024	Baird R W Subscribe to MarketBeat All Access for the recommendation accuracy rating	M. Ha Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
5/30/2024	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Neutral	$83.00	+17.76%
12/21/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$72.00 ➝ $79.00	+8.55%
9/5/2023	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Underperform ➝ Neutral	$79.00 ➝ $72.00	+17.51%
8/30/2023	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Overweight ➝ Equal Weight	$94.00 ➝ $73.00	+13.28%
7/12/2023	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Peer Perform
7/11/2023	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$80.00 ➝ $76.00	+12.91%
4/26/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$94.00 ➝ $87.00	+25.56%
2/14/2023	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$101.00 ➝ $97.00	+32.73%
2/8/2023	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral	$97.00 ➝ $74.00	+2.91%
2/8/2023	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$110.00 ➝ $95.00	+33.84%
12/14/2022	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target		$95.00 ➝ $99.00	+18.96%
9/22/2022	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$108.00 ➝ $101.00	+27.14%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:09 PM ET.

CNC Forecast - Frequently Asked Questions

What is Centene's forecast for 2024?: According to the research reports of 13 Wall Street equities research analysts, the average twelve-month stock price forecast for Centene is $85.75, with a high forecast of $97.00 and a low forecast of $69.00.
Should I buy or sell Centene stock right now?: 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Centene in the last year. There are currently 7 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CNC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CNC, but not buy additional shares or sell existing shares.
Does Centene's stock price have much upside?: According to analysts, Centene's stock has a predicted upside of 17.89% based on their 12-month stock forecasts.
Has Centene been downgraded by Wall Street analysts recently?: Over the previous 90 days, Centene's stock had 1 downgrade by analysts.
What analysts cover Centene?: Centene has been rated by research analysts at Barclays, Cantor Fitzgerald, Deutsche Bank Aktiengesellschaft, Jefferies Financial Group, JPMorgan Chase & Co., Oppenheimer, Stephens, TD Cowen, Truist Financial, and Wells Fargo & Company in the past 90 days.
Do Wall Street analysts like Centene more than its competitors?: Analysts like Centene less than other "medical" companies. The consensus rating for Centene is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CNC compares to other companies.